Ondine Boipharma Cor Ondine Biomedical Inc. ("Ondine Biomedical" or the "Company") Mail Out of Financial Statements and MD&A

 
TIDMOBP 
 
Ondine Biomedical Inc. ("Ondine Biomedical" or the "Company") Mail Out of Financial Statements and MD&A 
FOR:  ONDINE BIOMEDICAL INC. 
 
TSX, AIM SYMBOL:  OBP 
 
June 29, 2011 
 
Ondine Biomedical Inc. ("Ondine Biomedical" or the "Company") Mail Out of Financial Statements and MD&A 
 
VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 29, 2011) - Ondine Biomedical (TSX:OBP)(AIM:OBP) announces 
that, in accordance with regulatory requirements, it has mailed out to its shareholders its Financial 
Statements and Management Discussion and Analysis (MD&A) for the year ended December 31, 2010. Copies of these 
documents are available during normal business hours on weekdays (except Saturdays, Sundays and public 
holidays) free of charge from the Company's office at 888-1100 Melville Street, Vancouver, British Columbia, 
Canada. In addition, these documents are available on the SEDAR website at www.sedar.com and on the Company's 
website at www.ondinebio.com. 
 
 
-30- 
 
FOR FURTHER INFORMATION PLEASE CONTACT: 
 
Ondine Biomedical Inc. 
Carolyn Cross 
Chairman and Chief Executive Officer 
[phone] 
[e-mail] 
www.ondinebio.com 
 
OR 
 
Canaccord Genuity Limited 
Mark Williams 
Nominated Adviser 
[phone] 
 
 
 
 
Ondine Biomedical Inc.